Terms: = Bone cancer AND KLK2, P20151, 3817, ENSG00000167751, MGC12201, hK2, KLK2A2 AND Diagnosis
7 results:
1. Molecular Signature of
Alberge JB; Kraeber-Bodéré F; Jamet B; Touzeau C; Caillon H; Wuilleme S; Béné MC; Kampfenkel T; Sonneveld P; van Duin M; Avet-Loiseau H; Corre J; Magrangeas F; Carlier T; Bodet-Milin C; Chérel M; Moreau P; Minvielle S; Bailly C
J Nucl Med; 2022 Jul; 63(7):1008-1013. PubMed ID: 35086897
[TBL] [Abstract] [Full Text] [Related]
2. A Suite of Activity-Based Probes To Dissect the KLK Activome in Drug-Resistant Prostate cancer.
Lovell S; Zhang L; Kryza T; Neodo A; Bock N; De Vita E; Williams ED; Engelsberger E; Xu C; Bakker AT; Maneiro M; Tanaka RJ; Bevan CL; Clements JA; Tate EW
J Am Chem Soc; 2021 Jun; 143(23):8911-8924. PubMed ID: 34085829
[TBL] [Abstract] [Full Text] [Related]
3. Single-Cell Sequencing-Enabled Hexokinase 2 Assay for Noninvasive Bladder cancer diagnosis and Screening by Detecting Rare Malignant Cells in Urine.
Wang Z; Chen J; Yang L; Cao M; Yu Y; Zhang R; Quan H; Jiang Q; Hua Y; Wei W; Lu P; Wu J; Shi Q
Anal Chem; 2020 Dec; 92(24):16284-16292. PubMed ID: 33269906
[TBL] [Abstract] [Full Text] [Related]
4. New challenges in integrated diagnosis by imaging and osteo-immunology in bone lesions.
Schiano C; Soricelli A; De Nigris F; Napoli C
Expert Rev Clin Immunol; 2019 Mar; 15(3):289-301. PubMed ID: 30570412
[TBL] [Abstract] [Full Text] [Related]
5. Internalization of secreted antigen-targeted antibodies by the neonatal Fc receptor for precision imaging of the androgen receptor axis.
Thorek DL; Watson PA; Lee SG; Ku AT; Bournazos S; Braun K; Kim K; Sjöström K; Doran MG; Lamminmäki U; Santos E; Veach D; Turkekul M; Casey E; Lewis JS; Abou DS; van Voss MR; Scardino PT; Strand SE; Alpaugh ML; Scher HI; Lilja H; Larson SM; Ulmert D
Sci Transl Med; 2016 Nov; 8(367):367ra167. PubMed ID: 27903863
[TBL] [Abstract] [Full Text] [Related]
6. Overexpression of hexokinase-2 in giant cell tumor of bone is associated with false positive in bone tumor on FDG-PET/CT.
Hoshi M; Takada J; Oebisu N; Hata K; Ieguchi M; Nakamura H
Arch Orthop Trauma Surg; 2012 Nov; 132(11):1561-8. PubMed ID: 22825642
[TBL] [Abstract] [Full Text] [Related]
7. Proteomic analysis of conditioned media from the PC3, LNCaP, and 22Rv1 prostate cancer cell lines: discovery and validation of candidate prostate cancer biomarkers.
Sardana G; Jung K; Stephan C; Diamandis EP
J Proteome Res; 2008 Aug; 7(8):3329-38. PubMed ID: 18578523
[TBL] [Abstract] [Full Text] [Related]
